Replidyne files for IPO

Infectious disease company Replidyne (Louisville, Colo.) filed to raise up to $100 million in an IPO underwritten by Merrill Lynch; Morgan Stanley; Cowen; and Pacific Growth. An NDA for Replidyne's Or...